ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 6969

$1.47M Total Retail Price of All Prescriptions

Rank: 70 out of 6969

541 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

28% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,127 809 1 1
WARFARIN SODIUM 1,114 789 2 20
HYDROCODONE-ACETAMINOPHEN 650 445 S3 3 3
FUROSEMIDE 628 483 4 10
DONEPEZIL HCL 616 573 5 32
LEVOTHYROXINE SODIUM 599 403 6 5
OMEPRAZOLE 525 411 7 6
AMLODIPINE BESYLATE 505 408 8 4
DIVALPROEX SODIUM 474 299 9 103
TRAZODONE HCL 459 347 10 47
METFORMIN HCL 429 316 11 7
OLANZAPINE 409 246 12 139
NAMENDA 406 367 13 51
RISPERIDONE 353 280 14 88
LISINOPRIL 349 273 15 2
POTASSIUM CHLORIDE 337 233 16 30
FAMOTIDINE 315 240 17 37
METOPROLOL TARTRATE 304 262 18 13
QUETIAPINE FUMARATE 286 216 19 101
VALPROIC ACID 285 163 20 234
NOVOLIN R 270 211 21 161
MIRTAZAPINE 256 220 22 76
GABAPENTIN 255 200 23 17
LANTUS 205 137 24 50
LEVETIRACETAM 204 113 25 128
HYDROCHLOROTHIAZIDE 201 148 26 8
GLIPIZIDE 196 144 27 21
LACTULOSE 194 116 28 131
CITALOPRAM HBR 181 159 29 34
BACLOFEN 175 98 30 86
BENZTROPINE MESYLATE 172 82 R 31 177
CARVEDILOL 172 139 31 25
ALBUTEROL SULFATE 171 132 33 123
ALENDRONATE SODIUM 169 148 34 14
SEROQUEL 164 122 35 205
CARBIDOPA-LEVODOPA 163 152 36 119
PANTOPRAZOLE SODIUM 158 114 37 31
KLOR-CON M20 153 109 38 201
FLUOCINONIDE 148 148 39 134
MEGESTROL ACETATE 145 129 R 40 129
ENALAPRIL MALEATE 145 119 40 56
RISPERDAL CONSTA 135 110 42 380
RAMIPRIL 135 107 42 112
CLOZAPINE 131 55 44 309
NEXIUM 131 80 44 52
TAMSULOSIN HCL 128 110 46 23
PROCRIT 128 112 46 381
IBUPROFEN 127 82 48 29
ATENOLOL 123 106 49 9
IPRATROPIUM BROMIDE 117 92 50 179
OXYBUTYNIN CHLORIDE 115 80 51 126
PHENYTOIN 111 111 52 301
CEPHALEXIN 102 72 53 96
LOSARTAN POTASSIUM 102 91 53 12
MORPHINE SULFATE ER 101 77 S2 55 90
ZOLPIDEM TARTRATE 100 67 56 16
PREDNISONE 98 66 57 70
SERTRALINE HCL 95 88 58 38
PAROXETINE HCL 93 69 59 65
CLOPIDOGREL 93 80 59 48
TRIHEXYPHENIDYL HCL 92 91 R 61 459
SPIRONOLACTONE 92 66 61 102
BENAZEPRIL HCL 91 80 63 18
LEVOFLOXACIN 90 71 64 109
CIPROFLOXACIN HCL 90 74 64 64
GLYBURIDE 89 64 R 66 54
ESCITALOPRAM OXALATE 89 60 66 93
LOVASTATIN 89 89 66 15
TRAMADOL HCL 87 57 69 27
NYSTATIN 87 67 69 215
FLUOXETINE HCL 86 57 71 43
SANTYL 84 52 72 280
CLONIDINE HCL 84 41 72 59
DIGOXIN 84 71 72 71
LEVEMIR 82 63 75 232
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 50 75 114
NITROFURANTOIN MONO-MACRO 79 67 77 216
MELOXICAM 79 67 77 36
TRAVATAN Z 78 58 79 318
ADVAIR DISKUS 78 50 79 45
TRIAMCINOLONE ACETONIDE 77 51 81 55
HYDROMORPHONE HCL 76 27 S2 82 188
SPIRIVA 76 43 82 66
CYMBALTA 75 61 84 72
PHENYTOIN SODIUM EXTENDED 74 64 85 169
KLOR-CON 8 68 59 86 104
ISOSORBIDE DINITRATE 66 65 87 231
HUMULIN R 66 47 87 223
SEROQUEL XR 66 52 87 337
OXYBUTYNIN CHLORIDE ER 62 41 90 165
DILANTIN 62 39 90 417
JANTOVEN 61 14 92 304
PLAVIX 61 46 92 68
HUMALOG 61 32 92 167
ENOXAPARIN SODIUM 61 45 92 307
RANITIDINE HCL 60 54 96 46
GENERLAC 60 52 96 286
FENTANYL 58 30 S2 98 113
CARBAMAZEPINE 58 39 98 204
CELEBREX 57 57 100 67
METOCLOPRAMIDE HCL 55 48 101 136
HYDRALAZINE HCL 54 25 102 106
GALANTAMINE HBR 54 54 102 275
HEPARIN SODIUM 53 36 104 302
DIVALPROEX SODIUM ER 53 28 104 229
SINGULAIR 51 51 106 84
ATORVASTATIN CALCIUM 50 28 107 11
PRAVASTATIN SODIUM 50 48 107 19
FINASTERIDE 50 50 107 80
HYDROXYZINE HCL 50 33 R 107 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.